Conditions and Procedures
UW’s urologic oncology team offers several early-detection procedures for people at high risk of bladder cancer, along with innovative treatment options for early-stage and advanced bladder cancer. UW surgeons were early to adopt the novel blue light cystoscopy technology using Cysview, a fluorescent marker that binds to cancerous cells in the bladder allowing for detection of cancers that would be missed with traditional white light cystoscopy. In addition, UW is considered a high-volume surgical center for both robotic and open radical cystectomy, the gold standard in the treatment of muscle invasive bladder cancer. UW clinicians employ a multidisciplinary approach to determining which patients will benefit from chemotherapy prior to surgery and are actively working toward advancing imaging technologies such as magnetic resonance imaging (MRI) to improve bladder cancer staging. UW surgeons are national leaders and chairpersons of the national cancer survivorship programs sponsored by the Bladder Cancer Advocacy Network (BCAN).
The number of kidney cancer cases each year is increasing in the United States, and the Urologic Oncology team at UW is committed to providing complete cancer treatment to each kidney cancer patient treated at UW. The kidney cancer team will consider all options with each patient and will form a treatment plan according to an individual patient’s decisions. The Urologic Oncology Surgeons offer minimally invasive techniques using the newest technology to provide curative options with the least impact to patient’s lives. Patients with locally advanced or metastatic kidney cancer are seen by surgeons, medical oncologists and radiation specialists to provide treatment options that are only available at national centers of excellence. In addition, nutritional therapy and alternative therapy approaches are available to improve a patient’s quality of life during treatment.
In penile cancer cases, UW’s urologic oncology team works to preserve urinary and sexual function to ensure the best quality of life for patients with penile cancer. Many treatment options are available including topical chemotherapy, penile sparing surgery and Laser Ablation Treatment. In advanced cases, UW offers experienced surgeons and a multidisciplinary approach.
The UW Carbone Cancer Center is a world leader in prostate cancer research, and UW's urologic oncology team treats more than 350 new prostate cancer patients a year, offering innovative techniques in prevention, diagnosis and treatment.
In treatment of this cancer, most common in young and middle-aged men, UWs urologic oncology team uses a customized approach with surgery, radiation and/or chemotherapy, depending on the extent and cell type of the cancer. The UW is one of the few centers across the nation that offers patients the minimally invasive Robotic-Assisted Retroperitoneal Lymph Node Dissection. Additionally, sperm banking is available to patients prior to receiving treatment.
|Cysview© Blue Light Cystoscopy
This optical imaging agent used during bladder inspection allows surgeons to better detect bladder tumors, even smaller tumors that could be overlooked with standard-view cystoscopy.
|Laser Ablation Treatment
Laser therapy, in which a laser beam is used to destroy a tumor, may be an option in small, superficial tumors detected in early stages.
|Nerve-Sparing Radical Prostatectomy
A nerve-sparing prostatectomy allows for the preservation of nerves critical to maintaining erections after surgery.
A small percentage of patients are eligible for a partial cystectomy, which allows for surgical removal of the bladder tumor and surrounding bladder wall, preserving a portion of the original bladder.
During a radical (complete) nephrectomy, a surgeon removes an entire kidney for large or complex tumors. This surgery is performed laparoscopically or robotically whenever possible, which permits the kidney to be removed through a small incision and allows for a shorter recovery time for patients without compromising cancer control.
|Robotic-Assisted Retroperitoneal Lymph Node Dissection
Used in the surgical treatment of testicular cancer, Retroperitoneal Lymph Node Dissection typically requires a large, midline incision from the bottom of the sternum to several inches below the navel to remove the lymph nodes from the abdomen and pelvis. Use of the surgical robot for this complex operation allows the surgery to be performed through several smaller incisions and reduces patient recovery time.
For select patients, this robot-assisted surgery allows for the removal of cancerous bladders through a minimally invasive procedure with decreased blood loss.
|Robotic Partial Nephrectomy
In this procedure, a patient undergoes removal of just the tumor and keeps the rest of their normal kidney, allowing for normal renal function. Using a robotic approach allows for small incisions and less postoperative pain for many patients.
A less invasive approach to prostate removal, surgeons use robotic technology to remove cancerous tissue while at the same time sparing nerves around the prostate that control bladder function and sexual function.
Transurethral Resection of Bladder Tumor (TURBT) is done to remove small, shallow tumors from the inside surface of the bladder for the treatment of non-invasive bladder cancer. It is also used to biopsy larger or more aggressive cancers.